<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="18d7820d-471f-4ee2-9ec6-25d8d27c77de"><labelDrug name="Exforge HCT"><Normalization><mmtx cui="C2701249" preferredWord="Exforge HCT" semType="phsu, orch"/></Normalization></labelDrug><generic name="amlodipine valsartan and hydrochlorothiazide"/><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1" text="Drug Label for drug brand Exforge HCT, containing amlodipine valsartan and hydrochlorothiazide." type="negative"><entity charOffset="0:19" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Exforge HCT," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="50:70" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.1" text="amlodipine valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C1962523" phraseText="amlodipine valsartan" preferredWord="Amlodipine / valsartan" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="26:37" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.2" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="Drug Label for drug brand Exforge HCT," preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="75:94" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.2"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.1.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15" lineNumber="30" text="Do not coadminister aliskiren with Exforge HCT in patients with diabetes see Drug Interactions (7)." type="regular"><entity charOffset="0:19" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="64:72" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Exforge HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:46" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.4" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="aliskiren with Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.1"><relations><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.2" ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.4" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.15.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19" lineNumber="39" text="&lt;item&gt;Do not coadminister aliskiren with Exforge HCT in patients with diabetes (4)" type="regular"><entity charOffset="6:25" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="70:78" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.2" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="41:52" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.3" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="aliskiren with Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="26:35" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Exforge HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.1"><relations><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.3"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.2" ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.19.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34" text="Excessive hypotension, including orthostatic hypotension, was seen in 1.7% of patients treated with the maximum dose of Exforge HCT (10/320/25 mg) compared to 1.8% of valsartan/HCTZ (320/25 mg) patients, 0.4% of amlodipine/valsartan (10/320 mg) patients, and 0.2% of HCTZ/amlodipine (25/10 mg) patients in a controlled trial in patients with moderate to severe uncomplicated hypertension. " type="negative"><entity charOffset="177:181" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.0" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="of valsartan/HCTZ (320/25 mg) patients," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="212:232" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.1" text="amlodipine/valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C1962523" phraseText="0.4% of amlodipine/valsartan" preferredWord="Amlodipine / valsartan" semType="phsu, orch"/><RxNorm RxCui="729455"/></Normalization></entity><entity charOffset="120:131" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.2" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="of Exforge HCT (10/320/25 mg)" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="167:192" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.3" text="valsartan 320 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C1166306" phraseText="of valsartan/HCTZ (320/25 mg) patients," preferredWord="valsartan 320 MG" semType="clnd"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="272:282" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.4" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="0.2% of HCTZ/amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="267:271" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.5" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="0.2% of HCTZ/amlodipine" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.34.e.4"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35" text="In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur in patients receiving angiotensin receptor blockers. " type="negative"><entity charOffset="122:131" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="high doses of diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="189:218" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.1" text="angiotensin receptor blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0521942" phraseText="angiotensin receptor blockers." preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="36:47" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.2" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.35.e.1"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40" text="In the Valsartan in Acute Myocardial Infarction Trial (VALIANT), hypotension in post-myocardial infarction patients led to permanent discontinuation of therapy in 1.4% of valsartan-treated patients and 0.8% of captopril-treated patients." type="negative"><entity charOffset="210:219" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.0" text="captopril" type="Biomedical_Entity"><Normalization><mmtx cui="C0006938" phraseText="0.8% of captopril-treated patients." preferredWord="Captopril" semType="phsu, aapp"/><RxNorm RxCui="1998"/></Normalization></entity><entity charOffset="171:180" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.1" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="of valsartan-treated patients" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="7:16" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.2" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="In the Valsartan in Acute Myocardial Infarction Trial (VALIANT)," preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.40.e.0"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.43" text="If excessive hypotension occurs with Exforge HCT, the patient should be placed in a supine position and, if necessary, given an intravenous infusion of normal saline. " type="negative"><entity charOffset="152:165" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.43.e.0" text="normal saline" type="Biomedical_Entity"><Normalization><mmtx cui="C0445115" phraseText="an intravenous infusion of normal saline." preferredWord="Normal saline" semType="inch, phsu"/><RxNorm RxCui="125464"/></Normalization></entity><entity charOffset="37:48" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.43.e.1" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="occurs with Exforge HCT," preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.43.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.43.e.0"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.48" text="Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system and by diuretics. " type="negative"><entity charOffset="102:113" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.48.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="128:137" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.48.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="and by diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.48.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.48.e.1"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.49" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, or volume depletion) may be at particular risk of developing acute renal failure on Exforge HCT. " type="negative"><entity charOffset="282:293" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.49.e.0" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="on Exforge HCT." preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="78:89" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.49.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.49.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.49.e.0"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53" text="In the controlled trial of Exforge HCT in moderate to severe hypertensive patients, the incidence of hypokalemia (serum potassium 3.5 mEq/L) at any time post-baseline with the maximum dose of Exforge HCT (10/320/25 mg) was 10% compared to 25% with HCTZ/amlodipine (25/10 mg), 7% with valsartan/HCTZ (320/25 mg), and 3% with amlodipine/valsartan (10/320 mg). " type="negative"><entity charOffset="253:263" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="with HCTZ/amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="120:129" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium 3.5 mEq/" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="192:203" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="of Exforge HCT (10/320/25 mg)" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="324:344" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3" text="amlodipine/valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C1962523" phraseText="3% with amlodipine/valsartan" preferredWord="Amlodipine / valsartan" semType="phsu, orch"/><RxNorm RxCui="729455"/></Normalization></entity><entity charOffset="294:298" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="7% with valsartan/HCTZ (320/25 mg" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="284:309" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5" text="valsartan 320 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C1166306" phraseText="7% with valsartan/HCTZ (320/25 mg" preferredWord="valsartan 320 MG" semType="clnd"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="27:38" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="of Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="248:252" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="with HCTZ/amlodipine" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.53.e.7"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54" text="One patient (0.2%) discontinued therapy due to an adverse event of hypokalemia in each of the Exforge HCT and HCTZ/amlodipine groups. " type="negative"><entity charOffset="115:125" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.0" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="HCTZ/amlodipine groups." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="110:114" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.1" text="hctz" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="HCTZ/amlodipine groups." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="94:105" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.2" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="of the Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.54.e.1"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.55" text="The incidence of hyperkalemia (serum potassium 5.7 mEq/L) was 0.4% with Exforge HCT compared to 0.2-0.7% with the dual therapies." type="negative"><entity charOffset="72:83" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.55.e.0" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="0.4% with Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="37:46" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.55.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium 5.7 mEq/" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.55.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.55.e.0"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.56" text="Some patients with heart failure have developed increases in potassium on valsartan. " type="negative"><entity charOffset="74:83" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.56.e.0" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="on valsartan." preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.56.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="developed increases in potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.56.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.56.e.0"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.58" text="Dosage reduction and/or discontinuation of the diuretic and/or valsartan may be required." type="negative"><entity charOffset="63:72" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.58.e.0" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="47:55" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.58.e.1" text="diuretic" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="discontinuation of the diuretic" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.58.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.58.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70" lineNumber="101" text="Lithium generally should not be given with thiazides see Drug Interactions, Hydrochlorothiazide, Lithium (7)." type="regular"><entity charOffset="25:37" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.1" text="not be given" type="Caution_Interaction"/><entity charOffset="43:52" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.2" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.70.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.72" text="Hydrochlorothiazide may alter glucose tolerance and raise serum levels of cholesterol and triglycerides." type="negative"><entity charOffset="0:19" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.72.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="30:37" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.72.e.1" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose tolerance" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.72.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.72.e.1"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74" text="Hydrochlorothiazide decreases urinary calcium excretion and may cause elevations of serum calcium. " type="negative"><entity charOffset="90:97" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="elevations of serum calcium." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="38:45" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.74.e.1"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.75" text="Monitor calcium levels in patients with hypercalcemia receiving Exforge HCT." type="negative"><entity charOffset="8:15" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.75.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="Monitor calcium levels in patients" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="64:75" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.75.e.1" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="with hypercalcemia receiving Exforge HCT." preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.75.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.75.e.1"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.77" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="23:34" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.77.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.77.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.77.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.77.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88" lineNumber="118" text="Simvastatin: Coadministration of simvastatin with amlodipine increases the systemic exposure of simvastatin. " type="regular"><entity charOffset="61:92" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.1" text="increases the systemic exposure" type="Increase_Interaction"/><entity charOffset="50:60" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.2" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="with amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="96:107" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.3" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the systemic exposure of simvastatin." preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.88.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89" lineNumber="118" text="Limit the dose of simvastatin in patients on amlodipine to 20 mg daily." type="regular"><entity charOffset="0:14" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.1" text="Limit the dose" type="Caution_Interaction"/><entity charOffset="45:55" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.2" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="on amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="18:29" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.3" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0074554" phraseText="the dose of simvastatin" preferredWord="Simvastatin" semType="phsu, orch"/><RxNorm RxCui="36567"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.89.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90" lineNumber="119" text="CYP3A4 Inhibitors: Coadministration with CYP3A inhibitors (moderate and strong) result in increased systemic exposure to amlodipine warranting dose reduction. " type="regular"><entity charOffset="90:117" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.1" text="increased systemic exposure" type="Increase_Interaction"/><entity charOffset="41:57|59:67" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.2" text="CYP3A inhibitors moderate" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><entity charOffset="41:57|72:78" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.3" text="CYP3A inhibitors strong" type="Drug_Class"><Normalization><RxNorm RxCui="24348"/></Normalization></entity><entity charOffset="121:131" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.4" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="result in increased systemic exposure to amlodipine warranting dose reduction." preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="143:157" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.6" text="dose reduction" type="Increase_Interaction"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.3"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.4" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.4" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.1" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.90.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91" lineNumber="119" text="Monitor for symptoms of hypotension and edema when amlodipine is coadministered with CYP3A4 inhibitors to determine the need for dose adjustment." type="regular"><entity charOffset="24:35" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="51:61" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.2" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="85:102" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.3" text="CYP3A4 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><entity charOffset="40:45" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.5" text="edema" type="Specific_Interaction"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.91.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93" lineNumber="120" text="Blood pressure should be monitored when amlodipine is coadministered with CYP3A4 inducers." type="regular"><entity charOffset="25:34" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.1" text="monitored" type="Caution_Interaction"/><entity charOffset="40:50" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.2" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="amlodipine" preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="74:89" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.3" text="CYP3A4 inducers" type="Drug_Class"><Normalization><RxNorm RxCui="340933"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.93.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95" text="No clinically significant pharmacokinetic interactions were observed when valsartan was coadministered with amlodipine, atenolol, cimetidine, digoxin, furosemide, glyburide, hydrochlorothiazide, or indomethacin. " type="negative"><entity charOffset="174:193" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="74:83" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="108:118" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" text="amlodipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0051696" phraseText="coadministered with amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><entity charOffset="151:161" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3" text="furosemide" type="Biomedical_Entity"><Normalization><mmtx cui="C0016860" phraseText="furosemide," preferredWord="Furosemide" semType="phsu, orch"/><RxNorm RxCui="4603"/></Normalization></entity><entity charOffset="130:140" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4" text="cimetidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0008783" phraseText="cimetidine," preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="142:149" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="digoxin," preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="198:210" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6" text="indomethacin" type="Biomedical_Entity"><Normalization><mmtx cui="C0021246" phraseText="indomethacin." preferredWord="Indomethacin" semType="phsu, orch"/><RxNorm RxCui="5781"/></Normalization></entity><entity charOffset="163:172" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7" text="glyburide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="glyburide," preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="120:128" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="atenolol," preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.8" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.95.e.7"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96" lineNumber="122" text="The valsartan-atenolol combination was more antihypertensive than either component, but it did not lower the heart rate more than atenolol alone." type="regular"><entity charOffset="39:60" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.1" text="more antihypertensive" type="Specific_Interaction"/><entity charOffset="4:13" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.2" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="The valsartan-atenolol combination" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="14:22" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.3" text="atenolol" type="Drug"><Normalization><mmtx cui="C0004147" phraseText="The valsartan-atenolol combination" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.96.e.1" type="Specific_Interaction"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97" text="In vitro metabolism studies have indicated that CYP450 mediated drug interaction between valsartan and coadministered drugs are unlikely because of the low extent of metabolism see Pharmacokinetics Valsartan, (12.3)." type="negative"><entity charOffset="89:98" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.0" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="drug interaction between valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="55:63" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.1" text="mediated" type="Biomedical_Entity"><Normalization><mmtx cui="C0127400" phraseText="mediated" preferredWord="Mediator brand of benfluorex hydrochloride" semType="phsu, orch"/><RxNorm RxCui="985488"/></Normalization></entity><entity charOffset="198:207" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.2" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="Pharmacokinetics Valsartan," preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.97.e.2"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98" text="Coadministration of valsartan and warfarin did not change the pharmacokinetics of valsartan or the time-course of the anticoagulant properties of warfarin." type="negative"><entity charOffset="146:154" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="the time-course of the anticoagulant properties of warfarin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="118:131" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.1" text="anticoagulant" type="Biomedical_Entity"><Normalization><mmtx cui="C3536711" phraseText="the time-course of the anticoagulant properties of warfarin." preferredWord="Anti-coagulant [EPC]" semType="phsu"/><RxNorm RxCui="923"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.2" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="Coadministration of valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="34:42" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.3" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="82:91" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.4" text="valsartan" type="Biomedical_Entity"><Normalization><mmtx cui="C0216784" phraseText="the pharmacokinetics of valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.0"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.1"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.98.e.4"/></sentence><sentence biomedicalEntities="8" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99" lineNumber="125" text="Potassium: Concomitant use of valsartan with other agents that block the renin-angiotensin system, potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine. " type="regular"><entity charOffset="251:279" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.1" text="increases in serum potassium" type="Specific_Interaction"/><entity charOffset="175:196" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements," preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="30:39" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="Concomitant use of valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="51:97" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4" text="agents that block the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="with other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the renin-angiotensin system," preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="201:238" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5" text="salt substitutes containing potassium" type="Substance"><Normalization><mmtx cui="C0784217" phraseText="salt substitutes" preferredWord="Salt Substitute" semType="inch, phsu"/><mmtx cui="C0597277" phraseText="potassium" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="9547"/></Normalization></entity><entity charOffset="99:126" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6" text="potassium-sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium-sparing diuretics" preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="1437061"/></Normalization></entity><entity charOffset="134:148" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.8" text="spironolactone" type="Drug"><Normalization><mmtx cui="C0037982" phraseText="spironolactone," preferredWord="Spironolactone" semType="strd, phsu"/><RxNorm RxCui="9997"/></Normalization></entity><entity charOffset="150:161" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.10" text="triamterene" type="Drug"><Normalization><mmtx cui="C0040869" phraseText="triamterene," preferredWord="Triamterene" semType="phsu, orch"/><RxNorm RxCui="10763"/></Normalization></entity><entity charOffset="163:172" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.12" text="amiloride" type="Drug"><Normalization><mmtx cui="C0002502" phraseText="amiloride" preferredWord="Amiloride" semType="phsu, orch"/><RxNorm RxCui="142424"/></Normalization></entity><entity charOffset="287:300" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.14" text="heart failure" type="Specific_Interaction"><Normalization><mmtx cui="C0018801" phraseText="and in heart failure patients" preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="and in heart failure patients" preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.8" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6"/><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.10" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6"/><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.12" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.14"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.6" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.99.e.5"/></sentence><sentence biomedicalEntities="4" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101" lineNumber="126" text="Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including valsartan, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="247:253" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="coadministration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="265:291" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors," preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="298:333" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.4" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="345:354" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.5" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="valsartan," preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="370:401" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="127:134" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.8" text="elderly" type="SPAN"/><entity charOffset="136:151" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.9" text="volume-depleted" type="SPAN"/><entity charOffset="199:225" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.10" text="compromised renal function" type="SPAN"/><entity charOffset="422:441" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.2"/><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.5" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.4"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.9"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.10"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.12"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.1"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.9"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.10"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.8, Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.9, Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.10" ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.4" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.101.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103" lineNumber="126" text="Monitor renal function periodically in patients receiving valsartan and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="72:77" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.2" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="58:67" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.3" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.103.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104" lineNumber="127" text="The antihypertensive effect of angiotensin II receptor antagonists, including valsartan may be attenuated by NSAIDs including selective COX-2 inhibitors." type="regular"><entity charOffset="31:66" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.1" text="angiotensin II receptor antagonists" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="The antihypertensive effect of angiotensin II receptor antagonists," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="78:87" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.2" text="valsartan" type="Drug"><Normalization><mmtx cui="C0216784" phraseText="valsartan" preferredWord="valsartan" semType="phsu, orch"/><RxNorm RxCui="69749"/></Normalization></entity><entity charOffset="109:115" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.4" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="126:152" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.5" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors." preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="4:27|95:105" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.7" text="antihypertensive effect attenuated" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.2" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.1"/><classClassMembership drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.5"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.7"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.1" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.4" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.104.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105" lineNumber="128" text="Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. " type="irregular"><entity charOffset="181:192" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="83:112" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="with angiotensin receptor blockers," preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="133:142" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="114:128" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="194:206" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.6" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="212:237" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.8" text="changes in renal function" type="Specific_Interaction"/><entity charOffset="249:268" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.10" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.ddi.3"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.ddi.4"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.10"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.105.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106" lineNumber="128" text="Closely monitor blood pressure, renal function, and electrolytes in patients on Exforge HCT and other agents that affect the RAS." type="regular"><entity charOffset="8:15" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.1" text="monitor" type="Caution_Interaction"/><entity charOffset="80:91" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.2" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="on Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="102:128" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.3" text="agents that affect the RAS" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the RAS." preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the RAS." preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.106.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107" lineNumber="129" text="Do not coadminister aliskiren with Exforge HCT in patients with diabetes. " type="regular"><entity charOffset="0:19" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.1" text="Do not coadminister" type="Caution_Interaction"/><entity charOffset="20:29" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with Exforge HCT" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="35:46" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.3" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="aliskiren with Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="64:72" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes." preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes." preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.4" ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.107.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108" lineNumber="129" text="Avoid use of aliskiren with Exforge HCT in patients with renal impairment (GFR 60 mL/min)." type="regular"><entity charOffset="0:5" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="13:22" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="28:39" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.3" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="with Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><entity charOffset="57:73" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.4" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.4" ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.108.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111" lineNumber="132" text="Antidiabetic drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="71:88" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="71:88" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.4" text="insulin" type="Drug"/></anaphoraRelation><entity charOffset="0:18|20:31" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="46:63" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.6" text="Dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.6"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112" lineNumber="133" text="Lithium: Diuretic agents increase the risk of lithium toxicity. " type="regular"><entity charOffset="54:62" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="46:53" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="9:24" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.3" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113" text="Refer to the package insert for lithium preparations before use of such preparations with Exforge HCT. " type="negative"><entity charOffset="32:39" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113.e.0" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium preparations" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="90:101" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113.e.1" text="exforge hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2701249" phraseText="with Exforge HCT." preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113.e.0" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114" lineNumber="133" text="Monitoring of serum lithium concentrations is recommended during concurrent use." type="irregular"><entity charOffset="0:10" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114.e.1" text="Monitoring" type="Caution_Interaction"/><entity charOffset="20:27" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Monitoring of serum lithium concentrations" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113" text="Refer to the package insert for lithium preparations before use of such preparations with Exforge HCT. "><entity charOffset="90:101" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113.e.0" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="with Exforge HCT." preferredWord="Exforge HCT" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="4" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115" lineNumber="134" text="Non-steroidal anti-inflammatory drugs (NSAIDs and COX-2 selective inhibitors): When Exforge HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of diuretic is obtained." type="regular"><anaphoraRelation><anaphoraEntity charOffset="100:137" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.6" text="nonsteroidal anti-inflammatory agents" type="Expression"/><antecedentEntity charOffset="0-37" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.1" text="Non-steroidal anti-inflammatory drugs" type="Drug_Class"/></anaphoraRelation><entity charOffset="0:37" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.1" text="Non-steroidal anti-inflammatory drugs" type="Drug_Class"><Normalization><mmtx cui="C3536840" phraseText="Non-steroidal anti-inflammatory drugs" preferredWord="Nonsteroidal Anti-inflammatory Drug [EPC]" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="39:45" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.2" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="(NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="50:76" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.4" text="COX-2 selective inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="COX-2 selective inhibitors" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="382306"/></Normalization></entity><entity charOffset="184:192" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.8" text="observed" type="Caution_Interaction"/><entity charOffset="84:95" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.9" text="Exforge HCT" type="Drug"><Normalization><mmtx cui="C2701249" phraseText="Exforge HCT" preferredWord="Exforge HCT" semType="phsu, orch"/><RxNorm RxCui="722127"/></Normalization></entity><classClassMembership drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.2"/><classClassMembership drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.4"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.9"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.9" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.6" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115.e.8" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116" lineNumber="135" text="Carbamazepine: May lead to symptomatic hyponatremia." type="irregular"><entity charOffset="39:51" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116.e.1" text="hyponatremia" type="Specific_Interaction"><Normalization><mmtx cui="C0857122" phraseText="lead to symptomatic hyponatremia." preferredWord="hyponatremic" semType="dsyn"/></Normalization></entity><entity charOffset="0:13" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116.e.2" text="Carbamazepine" type="Drug"><Normalization><mmtx cui="C0006949" phraseText="Carbamazepine" preferredWord="Carbamazepine" semType="phsu, orch"/><RxNorm RxCui="2002"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111" text="Antidiabetic drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112" text="Lithium: Diuretic agents increase the risk of lithium toxicity. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113" text="Refer to the package insert for lithium preparations before use of such preparations with Exforge HCT. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114" text="Monitoring of serum lithium concentrations is recommended during concurrent use."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115" text="Non-steroidal anti-inflammatory drugs (NSAIDs and COX-2 selective inhibitors): When Exforge HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of diuretic is obtained."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117" lineNumber="136" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction. see Clinical Pharmacology (12.3)" type="regular"><entity charOffset="70:89" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.1" text="ion exchange resins" type="Drug_Class"><Normalization><mmtx cui="C0022014" phraseText="ion exchange resins" preferredWord="Ion Exchange Resins" semType="phsu, irda, bodm"/><RxNorm RxCui="1239134"/></Normalization></entity><entity charOffset="97:111" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.2" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="cholestyramine," preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="113:123" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.4" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="21:42" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.6" text="Staggering the dosage" type="Caution_Interaction"><Normalization><mmtx cui="C0344191" phraseText="Staggering" preferredWord="Cerebellar decompression injury" semType="dsyn"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.7" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the dosage of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.2" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.1"/><drugClassMembership drug="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.4" drugClass="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.1"/><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.6"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.7" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.1" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117.e.6" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118" lineNumber="137" text="Cyclosporine: Concomitant treatment with cyclosporine may increase the risk of hyperuricemia and gout-type complications." type="irregular"><entity charOffset="97:120" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.1" text="gout-type complications" type="Specific_Interaction"><Normalization><mmtx cui="C0018099" phraseText="gout-type complications." preferredWord="Gout" semType="dsyn"/></Normalization></entity><entity charOffset="41:53" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="Concomitant treatment with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="79:92" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.4" text="hyperuricemia" type="Specific_Interaction"><Normalization><mmtx cui="C0740394" phraseText="the risk of hyperuricemia" preferredWord="Hyperuricemia" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111" text="Antidiabetic drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112" text="Lithium: Diuretic agents increase the risk of lithium toxicity. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113" text="Refer to the package insert for lithium preparations before use of such preparations with Exforge HCT. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114" text="Monitoring of serum lithium concentrations is recommended during concurrent use."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115" text="Non-steroidal anti-inflammatory drugs (NSAIDs and COX-2 selective inhibitors): When Exforge HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of diuretic is obtained."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116" text="Carbamazepine: May lead to symptomatic hyponatremia."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction. see Clinical Pharmacology (12.3)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.2"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.4"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111" text="Antidiabetic drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112" text="Lithium: Diuretic agents increase the risk of lithium toxicity. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113" text="Refer to the package insert for lithium preparations before use of such preparations with Exforge HCT. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114" text="Monitoring of serum lithium concentrations is recommended during concurrent use."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115" text="Non-steroidal anti-inflammatory drugs (NSAIDs and COX-2 selective inhibitors): When Exforge HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of diuretic is obtained."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116" text="Carbamazepine: May lead to symptomatic hyponatremia."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction. see Clinical Pharmacology (12.3)"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119" lineNumber="140" text="&lt;item&gt;If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7)." type="regular"><entity charOffset="56:88" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.1" text="do not exceed doses greater than" type="Caution_Interaction"/><entity charOffset="104:115" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.2" text="simvastatin" type="Drug"><Normalization><mmtx cui="C0989915" phraseText="greater than 20 mg daily of simvastatin" preferredWord="Simvastatin 20 MG" semType="clnd"/><RxNorm RxCui="36567"/></Normalization></entity><entity charOffset="44:54" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.3" text="amlodipine" type="Drug"><Normalization><mmtx cui="C0051696" phraseText="coadministered with amlodipine," preferredWord="Amlodipine" semType="phsu, orch"/><RxNorm RxCui="104416"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120" lineNumber="142" text="&lt;item&gt;Antidiabetic drugs: Dosage adjustment of antidiabetic may be required (7)." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="47:59" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.e.2" text="antidiabetic" type="Expression"/><antecedentEntity charOffset="6-24" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.e.4" text="Antidiabetic drugs" type="Drug_Class"/></anaphoraRelation><entity charOffset="26:43" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.e.1" text="Dosage adjustment" type="Caution_Interaction"/><entity charOffset="6:24" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.e.4" text="Antidiabetic drugs" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="&gt;Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110" text="When administered concurrently the following drugs may interact with thiazide diuretics:"><entity charOffset="69:87" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.110.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics" preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.111" text="Antidiabetic drugs (oral agents and insulin): Dosage adjustment of the antidiabetic drug may be required."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.112" text="Lithium: Diuretic agents increase the risk of lithium toxicity. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.113" text="Refer to the package insert for lithium preparations before use of such preparations with Exforge HCT. "/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.114" text="Monitoring of serum lithium concentrations is recommended during concurrent use."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.115" text="Non-steroidal anti-inflammatory drugs (NSAIDs and COX-2 selective inhibitors): When Exforge HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of diuretic is obtained."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.116" text="Carbamazepine: May lead to symptomatic hyponatremia."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.117" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction. see Clinical Pharmacology (12.3)"/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.118" text="Cyclosporine: Concomitant treatment with cyclosporine may increase the risk of hyperuricemia and gout-type complications."/><middleSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.119" text="&lt;item&gt;If simvastatin is coadministered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7)."/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.120.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121" lineNumber="144" text="&lt;item&gt;Cholestyramine and colestipol: Reduced absorption of thiazides (12.3)." type="regular"><entity charOffset="37:55" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.1" text="Reduced absorption" type="Decrease_Interaction"/><entity charOffset="25:35" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.2" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="59:68" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.3" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Reduced absorption of thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="6:20" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.4" text="Cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="&gt;Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.2" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.3" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.1" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.4" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.121.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122" lineNumber="146" text="&lt;item&gt;Lithium: Diuretics increase risk of lithium toxicity. " type="regular"><entity charOffset="50:58" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="42:49" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="15:24" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.3" text="Diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.3" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.2" trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.123" lineNumber="146" text="Monitor serum lithium concentrations during concurrent use. " type="irregular"><entity charOffset="0:7" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.123.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="14:21" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.123.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Monitor serum lithium concentrations during concurrent use." preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.123.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.123.e.1"><relations><relation type="hasObject"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.123.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122" text="&lt;item&gt;Lithium: Diuretics increase risk of lithium toxicity. "><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.122.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125" lineNumber="148" text="&lt;item&gt;NSAID use may lead to increased risk of renal impairment and loss of anti-hypertensive effect (7)" type="irregular"><entity charOffset="67:99" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.1" text="loss of anti-hypertensive effect" type="Specific_Interaction"/><entity charOffset="6:11" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.2" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAID use" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="46:62" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.4" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="lead to increased risk of renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="lead to increased risk of renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.2"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.2"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.125.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126" lineNumber="150" text="&lt;item&gt;Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7)" type="irregular"><entity charOffset="91:102" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.1" text="hypotension" type="Specific_Interaction"/><entity charOffset="11:53" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.2" text="inhibition of the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C0035100" phraseText="&gt;Dual inhibition of the renin-angiotensin system" preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="&gt;Dual inhibition of the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="986536"/></Normalization></entity><entity charOffset="108:120" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.4" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="73:89" id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.6" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="Increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="Increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.ddi.1"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.2"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.ddi.2"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.2"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.ddi.3"><interaction trigger="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.2"/></relation><relation type="hasObject"><labelDrug text="Exforge HCT"/><normalization><mmtx><preferredWord>Exforge HCT</preferredWord><phraseText>aliskiren with Exforge HCT</phraseText><cuiCode>C2701249</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.18d7820d-471f-4ee2-9ec6-25d8d27c77de.s.126.e.2"/></sentence><positiveExamples number="36"/><negativeExamples number="123"/></document>